Direct cytocidal effect of galectin-9 localized on collagen matrices on human immune cell lines

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 6, 2014, Pages 1892-1901

  Fukata, Youko ^a   Itoh, Aiko ^a   Nonaka, Yasuhiro ^a   Ogawa, Takashi ^a   Nakamura, Takanori ^a   Matsushita, Osamu ^b   Nishi, Nozomu ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

Collagen; Collagen binding domain; Galectin; Immune suppression

Indexed keywords

COLLAGEN; COLLAGEN BINDING PEPTIDE; COLLAGENASE; ECALECTIN; GALECTIN 9 FUSION PROTEIN; HYBRID PROTEIN; OLIGOSACCHARIDE; PEPTIDE; UNCLASSIFIED DRUG; CLOSTRIDIUM HISTOLYTICUM COLLAGENASE COLLAGEN BINDING DOMAIN 112 HIGHLY STABLE AND SOLUBLE FORM OF GALECTIN 9 FUSION PROTEIN; CLOSTRIDIUM HISTOLYTICUM COLLAGENASE COLLAGEN BINDING DOMAIN 112 PROTEASE RESISTANT FORM OFGALECTIN 9 FUSION PROTEIN; CLOSTRIDIUM HISTOLYTICUM COLLAGENASE COLLAGEN BINDING DOMAIN 115 HIGHLY STABLE AND SOLUBLE FORM OF GALECTIN 9 FUSION PROTEIN; CLOSTRIDIUM HISTOLYTICUM COLLAGENASE COLLAGEN BINDING DOMAIN 115 PROTEASE RESISTANT FORM OF GALECTIN 9 FUSION PROTEIN; CLOSTRIDIUM HISTOLYTICUM COLLAGENASE COLLAGEN BINDING DOMAIN 302 HIGHLY STABLE AND SOLUBLE FORM OF GALECTIN 9 FUSION PROTEIN; CLOSTRIDIUM HISTOLYTICUM COLLAGENASE COLLAGEN BINDING DOMAIN 302 PROTEASE RESISTANT FORM OF GALECTIN 9 FUSION PROTEIN; CLOSTRIDIUM HISTOLYTICUM COLLAGENASE COLLAGEN BINDING DOMAIN 305 HIGHLY STABLE AND SOLUBLE FORM OF GALECTIN 9 FUSION PROTEIN; CLOSTRIDIUM HISTOLYTICUM COLLAGENASE COLLAGEN BINDING DOMAIN 305 PROTEASE RESISTANT FORM OF GALECTIN 9 FUSION PROTEIN; COLLAGEN BINDING PEPTIDE HIGHLY STABLE AND SOLUBLE FORM OF GALECTIN 9 FUSION PROTEIN; COLLAGEN BINDING PEPTIDE PROTEASE RESISTANT FORM OF GALECTIN 9 FUSION PROTEIN; COLLAGEN BINDING PROTEIN; COLLAGEN TYPE 1; LACTOSE; RECOMBINANT PROTEIN;

ARTICLE; BINDING AFFINITY; CELL CONTACT; CELL CULTURE; CELL DEATH; CELL GROWTH; CELL LINE; CONTROLLED STUDY; CYTOCIDAL ACTIVITY; DRUG ACTIVITY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; TRANSPLANTATION; ANTIPROLIFERATIVE ACTIVITY; CLOSTRIDIUM HISTOLYTICUM; COLLAGEN FIBRIL; CONCENTRATION RESPONSE; DRUG DETERMINATION; DRUG EFFECT; DRUG PROTEIN BINDING; GROWTH INHIBITION; IN VITRO STUDY; JURKAT CELL LINE; NONHUMAN; ORGAN TRANSPLANTATION; TISSUE ENGINEERING; WESTERN BLOTTING;

COLLAGEN; COLLAGEN-BINDING DOMAIN; GALECTIN; IMMUNE SUPPRESSION;

BINDING SITES; CELL PROLIFERATION; COLLAGEN; GALECTINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JURKAT CELLS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS;

EID: 84897099799     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.01.019     Document Type: Article

References (45)

1. S.H. Barondes, V. Castronovo, D.N. Cooper, R.D. Cummings, K. Drickamer, T. Feizi, M.A. Gitt, J. Hirabayashi, C. Hughes, K. Kasai, H. Leffler, F.-T. Liu, R. Lotan, A.M. Mercurio, M. Monsigny, S. Pillai, F. Poirer, A. Raz, P.W.J. Rigby, J.M. Rini, and J.L. Wang Galectins: a family of animal beta-galactoside-binding lectins Cell 76 1994 597 598 (Pubitemid 24070645)
2. J. Hirabayashi, and K. Kasai The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution Glycobiology 3 1993 297 304 (Pubitemid 23281277)
3. O. Tureci, H. Schmitt, N. Fadle, M. Pfreundschuh, and U. Sahin Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease J. Biol. Chem. 272 1997 6416 6422 (Pubitemid 27118120)
4. V.R. Wiersma, M. de Bruyn, W. Helfrich, and E. Bremer Therapeutic potential of Galectin-9 in human disease Med. Res. Rev. 33 2013 E102 E126
5. M. Seki, S. Oomizu, K.M. Sakata, A. Sakata, T. Arikawa, K. Watanabe, K. Ito, K. Takeshita, T. Niki, N. Saita, N. Nishi, A. Yamauchi, S. Katoh, A. Matsukawa, V. Kuchroo, and M. Hirashima Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis Clin. Immunol. 127 2008 78 88
6. Y. Kashio, K. Nakamura, M.J. Abedin, M. Seki, N. Nishi, N. Yoshida, T. Nakamura, and M. Hirashima Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway J. Immunol. 170 2003 3631 3636 (Pubitemid 36359232)
7. M. Moritoki, T. Kadowaki, T. Niki, D. Nakano, G. Soma, H. Mori, H. Kobara, T. Masaki, M. Kohno, and M. Hirashima Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3 PLoS One 8 2013 e60807
8. K. Ohtsubo, S. Takamatsu, M.T. Minowa, A. Yoshida, M. Takeuchi, and J.D. Marth Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes Cell 123 2005 1307 1321 (Pubitemid 41821787)
9. C. Zhu, A.C. Anderson, A. Schubart, H. Xiong, J. Imitola, S.J. Khoury, X.X. Zheng, T.B. Strom, and V.K. Kuchroo The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity Nat. Immunol. 6 2005 1245 1252 (Pubitemid 43045636)
10. S. Katoh, N. Ishii, A. Nobumoto, K. Takeshita, S.Y. Dai, R. Shinonaga, T. Niki, N. Nishi, A. Tominaga, A. Yamauchi, and M. Hirashima Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma Am. J. Respir. Crit. Care Med. 176 2007 27 35 (Pubitemid 47048051)
11. S. Bi, L.A. Earl, L. Jacobs, and L.G. Baum Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways J. Biol. Chem. 283 2008 12248 12258
12. R. Mishra, M. Grzybek, T. Niki, M. Hirashima, and K. Simons Galectin-9 trafficking regulates apical-basal polarity in Madin-Darby canine kidney epithelial cells Proc. Natl. Acad. Sci. U. S. A. 107 2010 17633 17638
13. T. Niki, S. Tsutsui, S. Hirose, S. Aradono, Y. Sugimoto, K. Takeshita, N. Nishi, and M. Hirashima Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation J. Biol. Chem. 284 2009 32344 32352
14. E.W. Su, S. Bi, and L.P. Kane Galectin-9 regulates T helper cell function independently of Tim-3 Glycobiology 21 2011 1258 1265
15. M. Seki, K.M. Sakata, S. Oomizu, T. Arikawa, A. Sakata, M. Ueno, A. Nobumoto, T. Niki, N. Saita, K. Ito, S.Y. Dai, S. Katoh, N. Nishi, M. Tsukano, K. Ishikawa, A. Yamauchi, V. Kuchroo, and M. Hirashima Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts Arthritis Rheum. 56 2007 3968 3976 (Pubitemid 350262324)
16. F.C. Chou, S.J. Shieh, and H.K. Sytwu Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice Eur. J. Immunol. 39 2009 2403 2411
17. M. Kanzaki, J. Wada, K. Sugiyama, A. Nakatsuka, S. Teshigawara, K. Murakami, K. Inoue, T. Terami, A. Katayama, J. Eguchi, H. Akiba, H. Yagita, and H. Makino Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes Endocrinology 153 2012 612 620
18. F. Wang, W. He, J. Yuan, K. Wu, H. Zhou, W. Zhang, and Z.K. Chen Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts Transpl. Immunol. 19 2008 12 19
19. W. He, Z. Fang, F. Wang, K. Wu, Y. Xu, H. Zhou, D. Du, Y. Gao, W.N. Zhang, T. Niki, M. Hirashima, J. Yuan, and Z.K. Chen Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice Transplantation 88 2009 782 790
20. L. Cai, H. Zhou, Z. Fang, J. Yuan, T. Niki, M. Hirashima, W. He, and Z.K. Chen Galectin-9 in combination with rapamycin induces cardiac allograft tolerance in mice Transplantation 96 2013 379 386
21. J. Leon-Villapalos, M. Eldardiri, and P. Dziewulski The use of human deceased donor skin allograft in burn care Cell Tissue Bank. 11 2010 99 104
22. N. Nishi, O. Matsushita, K. Yuube, H. Miyanaka, A. Okabe, and F. Wada Collagen-binding growth factors: production and characterization of functional fusion proteins having a collagen-binding domain Proc. Natl. Acad. Sci. U. S. A. 95 1998 7018 7023 (Pubitemid 28278099)
23. K. Uchida, O. Matsushita, K. Naruse, T. Mima, N. Nishi, S. Hattori, T. Ogura, G. Inoue, K. Tanaka, and M. Takaso Acceleration of periosteal bone formation by human basic fibroblast growth factor containing a collagen-binding domain from Clostridium histolyticum collagenase J. Biomed. Mater. Res. Part A 2014 (in press)
24. W. Zhao, B. Chen, X. Li, H. Lin, W. Sun, Y. Zhao, B. Wang, Q. Han, and J. Dai Vascularization and cellularization of collagen scaffolds incorporated with two different collagen-targeting human basic fibroblast growth factors J. Biomed. Mater. Res. Part A 82 2007 630 636 (Pubitemid 47258577)
25. S. Tada, T. Kitajima, and Y. Ito Design and synthesis of binding growth factors Int. J. Mol. Sci. 13 2012 6053 6072
26. N. Nishi, A. Itoh, A. Fujiyama, N. Yoshida, S. Araya, M. Hirashima, H. Shoji, and T. Nakamura Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins FEBS Lett. 579 2005 2058 2064 (Pubitemid 40469670)
27. A. Itoh, Y. Fukata, H. Miyanaka, Y. Nonaka, T. Ogawa, T. Nakamura, and N. Nishi Optimization of the inter-domain structure of galectin-9 for recombinant production Glycobiology 23 2013 920 925
28. O. Matsushita, C.M. Jung, J. Minami, S. Katayama, N. Nishi, and A. Okabe A study of the collagen-binding domain of a 116-kDa Clostridium histolyticum collagenase J. Biol. Chem. 273 1998 3643 3648 (Pubitemid 28109790)
29. O. Matsushita, C.M. Jung, S. Katayama, J. Minami, Y. Takahashi, and A. Okabe Gene duplication and multiplicity of collagenases in Clostridium histolyticum J. Bacteriol. 181 1999 923 933 (Pubitemid 29061576)
30. N. Matsushita, N. Nishi, M. Seki, R. Matsumoto, I. Kuwabara, F.T. Liu, Y. Hata, T. Nakamura, and M. Hirashima Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction J. Biol. Chem. 275 2000 8355 8360 (Pubitemid 30180176)
31. N. Nishi, A. Abe, J. Iwaki, H. Yoshida, A. Itoh, H. Shoji, S. Kamitori, J. Hirabayashi, and T. Nakamura Functional and structural bases of a cysteine-less mutant as a long-lasting substitute for galectin-1 Glycobiology 18 2008 1065 1073 (Pubitemid 352762841)
32. M.D. Abramoff, P.J. Magalhaes, and S.J. Ram Image processing with ImageJ Biophoton. Int. 11 2004 36 42
33. J.J. Wilson, O. Matsushita, A. Okabe, and J. Sakon A bacterial collagen-binding domain with novel calcium-binding motif controls domain orientation EMBO J. 22 2003 1743 1752 (Pubitemid 36460131)
34. L.H. Lu, R. Nakagawa, Y. Kashio, A. Ito, H. Shoji, N. Nishi, M. Hirashima, A. Yamauchi, and T. Nakamura Characterization of galectin-9-induced death of Jurkat T cells J. Biochem. 141 2007 157 172 (Pubitemid 46775753)
35. O. Matsushita, T. Koide, R. Kobayashi, K. Nagata, and A. Okabe Substrate recognition by the collagen-binding domain of Clostridium histolyticum class I collagenase J. Biol. Chem. 276 2001 8761 8770
36. J. Iwaki, H. Tateno, N. Nishi, T. Minamisawa, S. Nakamura-Tsuruta, Y. Itakura, J. Kominami, T. Urashima, T. Nakamura, and J. Hirabayashi The Galbeta-(syn)-gauche configuration is required for galectin-recognition disaccharides Biochim. Biophys. Acta 1810 2011 643 651
37. H. Sage, and P. Bornstein Characterization of a novel collagen chain in human placenta and its relation to AB collagen Biochemistry 18 1979 3815 3822
38. H. Sage, R.G. Woodbury, and P. Bornstein Structural studies on human type IV collagen J. Biol. Chem. 254 1979 9893 9900 (Pubitemid 10247826)
39. J.H. Aguilar, H.G. Jacobs, W.T. Butler, and L.W. Cunningham The distribution of carbohydrate groups in rat skin collagen J. Biol. Chem. 248 1973 5106 5113
40. R.G. Spiro Characterization and quantitative determination of the hydroxylysine-linked carbohydrate units of several collagens J. Biol. Chem. 244 1969 602 612
41. Y. Yang, Y. Zhao, B. Chen, Q. Han, W. Sun, Z. Xiao, and J. Dai Collagen-binding human epidermal growth factor promotes cellularization of collagen scaffolds Tissue Eng. Part A 15 2009 3589 3596
42. Q. Li, L. Tao, B. Chen, H. Ren, X. Hou, S. Zhou, J. Zhou, X. Sun, J. Dai, and Y. Ding Extrahepatic bile duct regeneration in pigs using collagen scaffolds loaded with human collagen-binding bFGF Biomaterials 33 2012 4298 4308
43. N. Lin, X. Li, T. Song, J. Wang, K. Meng, J. Yang, X. Hou, J. Dai, and Y. Hu The effect of collagen-binding vascular endothelial growth factor on the remodeling of scarred rat uterus following full-thickness injury Biomaterials 33 2012 1801 1807
44. S.J. de Souza, and R. Brentani Collagen binding site in collagenase can be determined using the concept of sense-antisense peptide interactions J. Biol. Chem. 267 1992 13763 13767
45. T. Takezawa, K. Ozaki, A. Nitani, C. Takabayashi, and T. Shimo-Oka Collagen vitrigel: a novel scaffold that can facilitate a three-dimensional culture for reconstructing organoids Cell Transplant. 13 2004 463 473 (Pubitemid 39163091)